Adial pharmaceuticals provides business update and reports first quarter 2022 financial results

Nears completion of onward™ phase 3 pivotal trial of ad04 for the treatment of alcohol use disorder; on track to report phase 3 results in the current quarter
ADIL Ratings Summary
ADIL Quant Ranking